Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Andretti Acquisition II Unit | POLEU | Oct 16, 2024 | 9.97 | 0.00 |
Anebulo Pharmaceuticals | ANEB | Oct 16, 2024 | 1.89 | -0.53 |
ANEW Medical | WENA | Oct 16, 2024 | 0.73 | 0.00 |
Angel Oak Financial Strategies | FINS | Oct 16, 2024 | 13.25 | +0.61 |
Angel Oak Mortgage REIT | AOMR | Oct 16, 2024 | 9.97 | +0.40 |
Anghami | ANGH | Oct 16, 2024 | 0.79 | +2.14 |
Angi A | ANGI | Oct 16, 2024 | 2.50 | -0.79 |
AngioDynamics | ANGO | Oct 16, 2024 | 6.22 | -1.74 |
Anglogold Ashanti | AU | Oct 16, 2024 | 28.00 | +1.63 |
Anheuser-Busch InBev ADR | BUD | Oct 16, 2024 | 65.30 | -0.20 |
ANI Pharmaceuticals | ANIP | Oct 16, 2024 | 59.66 | +1.81 |
Anika Therapeutics | ANIK | Oct 16, 2024 | 25.21 | +0.24 |
Anixa Biosciences | ANIX | Oct 16, 2024 | 3.06 | +0.99 |
Annaly Capital Management | NLY | Oct 16, 2024 | 20.16 | +1.00 |
Annaly Capital Management F Pref | NLY-F | Oct 16, 2024 | 25.67 | -0.35 |
Annaly Capital Management G Pref | NLY-G | Oct 16, 2024 | 25.28 | +0.06 |
Annaly Capital Management I Pref | NLY-I | Oct 16, 2024 | 25.60 | +0.01 |
Annexon | ANNX | Oct 16, 2024 | 7.62 | +2.28 |
Annovis Bio | ANVS | Oct 16, 2024 | 9.14 | +14.54 |
ANSYS | ANSS | Oct 16, 2024 | 323.77 | -1.47 |
Antelope Enterprise | AEHL | Oct 16, 2024 | 0.65 | -5.19 |
Anterix | ATEX | Oct 16, 2024 | 32.95 | +0.52 |
Antero Midstream | AM | Oct 16, 2024 | 15.31 | 0.00 |
Antero Resources | AR | Oct 16, 2024 | 27.24 | -0.40 |
Anywhere Real Estate | HOUS | Oct 16, 2024 | 4.65 | -0.43 |
Aon | AON | Oct 16, 2024 | 358.39 | +0.14 |
APA | APA | Oct 16, 2024 | 24.80 | -0.20 |
Apartment Investment and Management | AIV | Oct 16, 2024 | 8.75 | +0.69 |
Apellis Pharmaceuticals | APLS | Oct 16, 2024 | 27.95 | 0.00 |
APi Group | APG | Oct 16, 2024 | 33.68 | +0.33 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.